Division of Neuroscience Research and, Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston, South Carolina.
Alcohol Clin Exp Res. 2013 Nov;37(11):1882-90. doi: 10.1111/acer.12168. Epub 2013 Jul 26.
Ethanol (EtOH) inhibition of N-methyl-d-aspartate (NMDA) receptors is poorly understood due in part to the organizational complexity of the receptor that provides ample locations for sites of action. Among these, the N-terminal domain (NTD) of NMDA receptor subunits contains binding sites for a variety of modulatory agents including zinc, protons, and GluN2B selective antagonists such as ifenprodil or Ro-25-6981. EtOH inhibition of neuronal NMDA receptors expressed in some brain areas has been reported to be occluded by the presence of ifenprodil or similar compounds suggesting that the NTD may be important in regulating the EtOH sensitivity of NMDA receptors.
Wild-type GluN1 and GluN2 subunits and those in which the coding sequence for the NTD was deleted were expressed in HEK293 cells. Whole-cell voltage-clamp recording was used to assess EtOH inhibition of wild-type and mutant receptors lacking the NTD.
As compared to wild-type GluN1/GluN2A receptors, EtOH inhibition was slightly greater in cells expressing GluN2A subunits lacking the NTD. In contrast, GluN2B N-terminal deletion mutants showed normal EtOH inhibition while those lacking the NTD in both GluN1 and GluN2B subunits had decreased EtOH inhibition as compared to wild-type receptors. NTD lacking GluN2B receptors were insensitive to ifenprodil but retained normal sensitivity to EtOH.
These findings indicate that the NTD modestly influences the EtOH sensitivity of NMDA receptors in a subunit-dependent manner. They also show that ifenprodil's actions on GluN2B-containing receptors can be dissociated from those of EtOH. These results suggest that while the NTD is not a primary site of action for EtOH on NMDA receptors, it likely affects sensitivity via actions on intrinsic channel properties.
由于 NMDA 受体结构复杂,为作用位点提供了充足的位置,因此乙醇(EtOH)对 NMDA 受体的抑制作用仍不清楚。其中,NMDA 受体亚基的 N 端结构域(NTD)包含各种调节因子的结合位点,包括锌、质子和 GluN2B 选择性拮抗剂,如ifenprodil 或 Ro-25-6981。据报道,在一些脑区表达的神经元 NMDA 受体,其 EtOH 抑制作用被 ifenprodil 或类似化合物所阻断,这表明 NTD 可能在调节 NMDA 受体对 EtOH 的敏感性方面发挥重要作用。
在 HEK293 细胞中表达野生型 GluN1 和 GluN2 亚基以及 NTD 编码序列缺失的亚基。使用全细胞膜片钳记录来评估缺乏 NTD 的野生型和突变受体对 EtOH 的抑制作用。
与野生型 GluN1/GluN2A 受体相比,缺乏 NTD 的 GluN2A 亚基表达的细胞中 EtOH 抑制作用略大。相比之下,GluN2B N 端缺失突变体显示出正常的 EtOH 抑制作用,而 GluN1 和 GluN2B 亚基均缺乏 NTD 的突变体与野生型受体相比,EtOH 抑制作用降低。缺乏 NTD 的 GluN2B 受体对 ifenprodil 不敏感,但对 EtOH 保持正常敏感性。
这些发现表明,NTD 以亚基依赖的方式适度影响 NMDA 受体对 EtOH 的敏感性。它们还表明,ifenprodil 对包含 GluN2B 的受体的作用可以与 EtOH 的作用分离。这些结果表明,尽管 NTD 不是 EtOH 对 NMDA 受体的主要作用位点,但它可能通过对内在通道特性的作用影响敏感性。